Illustrative

Testing biomarker-based treatments for prostate cancer

Froedtert & MCW·Mar 10

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Researchers are exploring the use of biomarker-based treatments for prostate cancer. This approach involves using biomarkers to guide treatment decisions. The development of these treatments is currently being tested.

Full coverage

Identification of biomarkers for non-invasive diagnosis and risk stratification in prostate cancer using NMR-based metabolomics and machine learning

Nature·Apr 8

Prostate Cancer Biomarker Test First to Predict Hormone Therapy Response

Inside Precision Medicine·Oct 8

Utilization of artificial intelligence in prostate cancer detection: a comprehensive review of innovations in screening and diagnosis

Frontiers·Nov 26

Advancing Biomarker Testing Across GU, Lung, and Myeloma Care

The American Journal of Managed Care® (AJMC®)·Jan 22

Genomic Testing in Prostate Cancer: Management, Applications, and Treatment Selection - Joaquin Mateo

UroToday·Oct 31

Genomic testing helps inform treatment intensity decisions in intermediate-risk prostate cancer

Urology Times·Oct 2

New urine test may help tailor bladder cancer treatment

Medical News Today·Apr 21

Johns Hopkins Investigators Create New Urine-based Test to ID Prostate Cancers

Johns Hopkins Medicine·Sep 2

View original report at Froedtert & MCW ↗

Fetching the latest headlines…